Fiche centre
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an — China
Essais liés11clinical trials
VilleXi'anlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06179069
Essais cliniques associés
11| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Selatogrel | Maladie coronarienne | Phase 3 | NCT04957719 | SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION |
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| Coronary and peripheral stents | Maladie coronarienne | À vérifier | NCT04573660 | AV-MDR — Abbott Vascular Medical Device Registry | RECRUITING |
| ZL-1310 | Cancer | Phase 1 | NCT06179069 | A Study of ZL-1310 in Subjects With Small Cell Lung Cancer | RECRUITING |
| ZL-1310 | Cancer | Phase 3 | NCT07218146 | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT05810038 | A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. | COMPLETED |
| M5049 low dose | Lupus | Phase 2 | NCT05540327 | The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) | ACTIVE_NOT_RECRUITING |
| PF-06821497 | Cancer | Phase 3 | NCT06629779 | A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. | RECRUITING |
| Rina-S | Cancer | Phase 3 | NCT07604766 | RAINFOL-02 — An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China | RECRUITING |
| Telitacicept | Lupus | Phase 1 | NCT05247203 | Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus | COMPLETED |
| ET1402L1-ARTEMIS™ T cells -IV | Cancer | Phase 1 | NCT03888859 | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma | COMPLETED |